National Psoriasis Foundation

Drug Pipeline

« Back to the pipeline

Company

Boehringer-Ingelheim

Therapeutic Approach

Injectables

Indication

Psoriatic Arthritis

Mechanism

anti-inflammatory (IL-23 blocker)

Phase

Phase II

Get the latest research news and tips on managing your psoriasis and psoriatic arthritis.